Related Experiment Video
Updated: Apr 22, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection
Erlangga Yusuf1, Nancy Perrottet, Christina Orasch
11 Infectious Diseases Service, Department of Medicine, Lausanne University Hospital , Lausanne, Switzerland .
Background:
Daptomycin is used increasingly to treat prosthetic joint infection (PJI). A possible side effect of this drug is eosinophilic pneumonia. We describe two patients with PJI treated with daptomycin who had this side effect with different clinical presentations.
Methods:
Case reports and review of the literature.
Results:
The first case was a 64-year-old male who received daptomycin as a part of the treatment for PJI caused by methicillin-resistant Staphylococcus epidermidis (MRSE). He developed fever without other symptoms; bronchoalveolar lavage (BAL) revealed eosinophils. The second was a 61-year-old male who also used daptomycin as part of the treatment of PJI caused by MRSE and developed severe lung symptoms. Bronchoalveolar lavage and pleural fluid showed an increased number of eosinophils.
Conclusion:
Daptomycin-induced pneumonia can present with a wide range of symptoms, from fever alone to severe lung symptoms. Surgeons should be aware of this possible side effect when prescribing daptomycin.
Insights
Daptomycin treatment for prosthetic joint infection can cause eosinophilic pneumonia. This side effect may present with mild fever or severe lung symptoms, requiring clinical awareness.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Daptomycin is increasingly prescribed for prosthetic joint infections (PJI).
- Eosinophilic pneumonia is a potential adverse effect of daptomycin therapy.
- This report details two cases of PJI patients experiencing daptomycin-induced eosinophilic pneumonia.
Observation:
- Two male patients with MRSE-PJI were treated with daptomycin.
- Patient 1 presented with fever; bronchoalveolar lavage (BAL) showed eosinophils.
- Patient 2 developed severe respiratory symptoms; BAL and pleural fluid analysis revealed eosinophilia.
Findings:
- Daptomycin-induced pneumonia can manifest with varied clinical presentations.
- Symptoms ranged from isolated fever to significant pulmonary distress.
- Diagnostic confirmation involved identifying eosinophils in respiratory samples.
Implications:
- Clinicians, especially surgeons, must consider daptomycin-induced pneumonia in patients with PJI.
- Awareness of this potential adverse effect is crucial for timely diagnosis and management.
- Prompt recognition can prevent severe respiratory complications associated with daptomycin use.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment

